Cardiovascular Devices Global Market Report 2025

Cardiovascular Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiovascular devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for cardiovascular devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Cardiovascular Surgery Devices And Equipment; Cardiac Rhythm Management (CRM) Devices And Equipment; Interventional Cardiology Devices And Equipment; Defibrillator Devices And Equipment; Peripheral Vascular Devices And Equipment; Prosthetic Heart Valve Devices And Equipment; Electrophysiology Devices And Equipment; Cardiac Assist Devices And Equipment

2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users

3) By Type of Expenditure: Public; Private

4) By Product: Instruments Or Equipment; Disposables

Subsegments:

1) By Cardiovascular Surgery Devices And Equipment: Coronary Artery Bypass Graft (CABG) Equipment; Heart Valve Repair And Replacement Devices; Aortic Aneurysm Repair Devices; Cardiopulmonary Bypass Equipment; Other Cardiovascular Surgery Devices

2) By Cardiac Rhythm Management (CRM) Devices And Equipment: Pacemakers; Defibrillators; Cardiac Resynchronization Therapy (CRT) Devices

3) By Interventional Cardiology Devices And Equipment: Stents (Drug-Eluting, Bare-Metal); Catheters (Balloon, Diagnostic, Guiding); Angioplasty Equipment; Guidewires; Other Interventional Cardiology Devices

4) By Defibrillator Devices And Equipment: Implantable Cardioverter Defibrillators (ICDs); Automated External Defibrillators (AEDs); Wearable Defibrillators; External Defibrillators

5) By Peripheral Vascular Devices And Equipment: Peripheral Stents; Balloons (Peripheral Angioplasty); Embolic Protection Devices; Endovenous Laser Devices; Other Peripheral Vascular Devices

6) By Prosthetic Heart Valve Devices And Equipment: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves (TAVR); Other Prosthetic Heart Valve Devices

7) By Electrophysiology Devices And Equipment: Ablation Catheters; Electrophysiology Mapping Systems; ECG And EKG Systems; Cardiac Mapping And Navigation Systems; Other Electrophysiology Devices

8) By Cardiac Assist Devices And Equipment: Ventricular Assist Devices (LVADs); Intra-Aortic Balloon Pumps; Total Artificial Heart; Extracorporeal Membrane Oxygenation (ECMO); Other Cardiac Assist Devices

Companies Mentioned: Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Edwards Lifesciences Corporation; Johnson & Johnson; Terumo Corporation; Getinge AB; Teleflex Incorporated; Becton, Dickinson and Company; Siemens Healthineers AG; Fresenius SE & Co. KGaA; GE HealthCare Technologie Inc.; Stryker Corporation; B. Braun Medical Pvt. Ltd.; Baxter International Inc.; Danaher Corporation; Fujifilm Holdings Corporation; Canon Medical Systems Corporation; MicroPort Scientific America Inc.; W L Gore & Associates Inc.; AngioDynamics Inc.; CryoLife Inc.; Endologix LLC; Lombard Medical Limited; Avinger Inc.; Abiomed Inc.; Biosensors International Group Ltd.; Biotronik SE and Co. KG; CeloNova BioSciences Inc.; LeMaitre Vascular Inc.; Nano Therapeutics Pvt. Ltd.

Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Show more